United States · FDA National Drug Code directory
SAXAGLIPTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-726_4d1a25c6-4ffc-4714-98a9-c4dcb2049d6d
- Product NDC
- 68462-726
- Form
- TABLET, FILM COATED
- Composition / generic term
- SAXAGLIPTIN
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230731
- Source listing expiry
- 20271231
Source-listed ingredients
- SAXAGLIPTIN HYDROCHLORIDE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (68462-726-05) · 68462-726-05
- 30 TABLET, FILM COATED in 1 BOTTLE (68462-726-30) · 68462-726-30
- 90 TABLET, FILM COATED in 1 BOTTLE (68462-726-90) · 68462-726-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →